Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
GMR Solutions Inc.
13G
GMRS · 38013D106
|
6.2% |
8/20/2026
Event 8/13/2026
|
|||
| North Peak Capital Management, LLC | 6.2% | ||||
| North Peak Capital GP, LLC | 4.7% | ||||
| North Peak Capital Partners, LP | 0.4% | ||||
| North Peak Capital Partners II, LP | 2.1% | ||||
| North Peak Capital Alpha Fund, LP | 2.0% | ||||
| North Peak Capital Ultra Fund, LP | 0.3% | ||||
| Michael Kevin Kahan | 6.2% | ||||
| Jeremy Steven Kahan | 6.2% | ||||
|
Haemonetics Corp
13G/A
HAE · 405024100
|
0% |
5/13/2026
Event 3/31/2026
|
|||
| North Peak Capital Management, LLC | 0% | ||||
| North Peak Capital GP, LLC | 0% | ||||
| North Peak Capital Partners, LP | 0% | ||||
| North Peak Capital Partners II, LP | 0% | ||||
| North Peak Capital Alpha Fund, LP | 0% | ||||
| North Peak Capital Ultra Fund, LP | 0% | ||||
| Michael Kevin Kahan | 0% | ||||
| Jeremy Steven Kahan | 0% | ||||
|
Agilon Health, Inc.
13G/A
AGL · 00857U107
|
9.5% |
11/13/2025
Event 9/30/2025
|
|||
| North Peak Capital Management, LLC | 9.5% | ||||
| North Peak Capital GP, LLC | 7.7% | ||||
| North Peak Capital Partners, LP | 0.5% | ||||
| North Peak Capital Partners II, LP | 4.4% | ||||
| North Peak Capital Alpha Fund, LP | 2.4% | ||||
| North Peak Capital Ultra Fund, LP | 0.4% | ||||
| Michael Kevin Kahan | 7.7% | ||||
| Jeremy Steven Kahan | 7.7% | ||||